Relationship between expression of E-cadherin-catenin complex and clinicopathologic characteristics of pancreatic cancer

World Journal of Gastroenterology

Volumn 9, Issue 2, 2003, Pages 368-372

  Li, Yu Jun ^a   Ji, Xiang Rui ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; BETA CATENIN; BIOLOGICAL MARKER; UVOMORULIN;

ACINAR CELL; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INFILTRATION; CANCER INVASION; CANCER SIZE; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE DELETION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; METASTASIS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS CARCINOMA; PANCREAS DUCT; PATHOLOGY; PROTEIN EXPRESSION; STAINING; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TUMOR DIFFERENTIATION;

EID: 0037442044     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i2.368     Document Type: Article

References (43)

1. Wagman R, Grann A. Adjuvant therapy for pancreatic cancer: Current treatment approaches and future challenges. Surg Clin North Am 2001; 81: 667-681
2. Gebhardt C, Meyer W, Reichel M, Wunsch PH. Prognostic factors in the operative treatment of ductal pancreatic carcinoma. Langenbecks Arch Surg 2000; 385: 14-20
3. Kayahara M, Nagakawa T, Ohta T, Kitagawa H, Ueno K, Tajima H, Elnemr A, Miwa K. Analysis of paraaortic lymph node involvement in pancreatic carcinoma: A significant indication for surgery? Cancer 1999; 85: 583-590
4. Carr JA, Ajlouni M, Wollner I, Wong D, Velanovich V. Adenocarcinoma of the head of the pancreas: Effects of surgical and nonsurgical therapy on survival - A ten-year experience. Am Surg 1999; 65: 1143-1149
5. Benassai G, Mastrorilli M, Mosella F, Mosella G. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma. J Exp Clin Cancer Res 1999; 18: 23-28
6. Beavon IR. The E-cadherin-catenin complex in tumor metastasis: Structure, function and regulation. Eur J Cancer 2000; 36: 1607-1620
7. Korn WM. Moving toward and understanding of the metastatic process in hepatocellular carcinoma. World J Gastroenterol 2001; 7: 777-778
8. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 2000; 10: 415-433
9. Bair EL, Massey CP, Tran NL, Borchers AH, Heimark RL, Cress AE, Bowden GT. Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocuitures of malignant oral squamous cell carcinoma cells and dermal fibroblasts. Exp Cell Res 2001; 270: 259-267
10. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998; 153: 333-339
11. Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumor-suppressor gene. Trends Biochem Sci 1999; 24: 73-76
12. Van Aken E, Den Wever O, Correia Da Rocha AS, Mareel M. Defective E-cadherin/catenin complexes in human cancer. Virchows Arch 2001; 439: 725-751
13. Wijnhoven BP, Dinjens WN, Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 2000; 87: 992-1005
14. Debruyne P, Vermeulen S, Mareel M. The role of the E-cadherin/catenin complex in gastrointestinal cancer. Acta Gastroenterol Belg 1999; 62: 393-402
15. Behrens J. Cadherins and catenins: Role in signal transduction and tumor progression. Cancer Metastasis Rev 1999; 18: 15-30
16. El-Bahrawy MA, Pignatelli M. E-cadherin and catenins: Molecules with versatile roles in normal and neoplastic epithelial cell biology. Microsc Res Tech 1998; 43: 224-232
17. Bremnes RM, Veve R, Hirsch FR, Franklin WA. The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 2002; 36: 115-124
18. Berx G, Van Roy F. The E-cadherin/catenin complex: An important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 2001; 3: 289-293
19. Nollet F, Berx G, Van Roy F. The role of the E-cadherin/catenin complex in the development and progression of cancer. Mol Cell Biol Res Commun 1999; 2: 77-85
20. Kitagawa T, Matsumoto K, Nagafuchi A, Tsukita S, Suzuki H. Co-expression of E-cadherin and alpha-catenin molecules in colorectal cancer. Surg Today 1999; 29: 511-518
21. Giulianotti PC, Boggi U, Fornaciari G. Prognostic value of histological grading in ductal adenocarcinoma of the pancreas. Int J Pancreatol 1995; 17: 279-289
22. Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJ. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric cancer: Relationship with patient survival. Gastroenterology 1997; 112: 46-54
23. Hirohashi S. Molecular aspects of adhesion-epigenetic mechanism for inactivation of the E-cadherin-mediated cell adhesion system in cancers. Verh Dtsch Ges Pathol 2000; 64: 28-32
24. Maeno Y, Moroi S, Nagashima H, Noda T, Shiozaki H, Monden M. Alpha-catenin deficient F9 cells differentiate into signet ring cells. Am J Pathol 1999; 354: 1323-1328
25. Chalmers IJ, Hofler H, Atkinson MJ. Mapping of a cadherin gene cluster to a region of chromosome 5 subject to frequent allelic loss in carcinoma. Genomics 1999; 57: 160-163
26. Li LC, Chui RM, Sasaki M, Nakajima K, Perinchery G, Au HC, Nojima D, Carroll P, Dahiya R. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 2000; 60: 873-876
27. Maruyama K, Ochiai A, Nakamura S, Baba S, Hirohashi S. Dysfunction of E-cadherin-catenin system in invasion and metastasis of colorectal cancer. Nippon Geka Gakkai Zasshi 1998; 99: 402-408
28. Mareel M, Van Roy F. The human E-cadherin/catenin complex: A potent invasion and tumor suppressor. Verh K Acad Geneeskd Belg 1998; 60: 576-598
29. Tanakao M, Kitajima Y, Edakuni G, Sato S, Miyazaki K. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Br J Surg 2002; 89: 236-244
30. Fujioka T, Takebayashi Y, Kihana T, Kusanagi Y, Hamada K, Ochi H, Uchida T, Fukumoto M, Ito M. Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma. Oncol Rep 2001; 8: 249-255
31. Dai D, Chen J, Xu H. The clinical significance of E-cadherin and alpha-catenin expression in human gastric cancer. Zhonghua Zhongliu Zazhi 2001; 23: 35-38
32. Joo YE, Rew JS, Kim HS, Choi SH, Park CS, Kim SJ. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers. Digestion 2001; 64: 111-119
33. Karayiannakis AJ, Syrigos KN, Polychronidis A, Simopoulos C. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: Correlation with E-cadherin expression, pathological features and prognosis. Anticancer Res 2001; 21: 4127-4134
34. Karayiannakis AJ, Syrigos KN, Chatzigianni E, Papanikalaou S, Alexiou D, Kalahanis N, Rosenberg T, Bastounis E. Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer. Anticancer Res 1998; 18: 4177-4180
35. Furuyama H, Arii S, Mori A, Imamura M. Role of E-cadherin in peritoneal dissemination of the pancreatic cancer cell line, panc-1, through regulation of cell to cell contact. Cancer Lett 2000; 157: 201-209
36. Yonemasu H, Takashima M, Nishiyama KI, Ueki T, Yao T, Tanaka M, Tsuneyoshi M. Phenotypical characteristics of undifferentiated carcinoma of the pancreas: A comparison with pancreatic ductal adenocarcinoma and relevance of E-cadherin, alpha catenin and beta catenin expression. Oncol Rep 2001; 8: 745-752
37. Takao S, Che X, Fukudome T, Natsugoe S, Ozawa M, Aikou T. Down-regulation of E-cadherin by antisense oligonucleotide enhances basement membrane invasion of pancreatic carcinoma cells. Hum Cell 2000; 13: 15-21
38. Gunji N, Oda t, Todoroki T, Kanazawa N, Kawamoto T, Yuzawa K, Scarpa A, Fukao K. Pancreatic carcinoma: Correlation between E-cadherin and alpha-catenin expression status and liver metastasis. Cancer 1998; 82: 1649-1656
39. Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Kosma VM. Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer. Br J Cancer 1999; 80: 477-482
40. Inagawa S, Itabashi M, Adachi S, Kawamoto T, Hori M, Shimazaki J, Yoshimi F, Fukao K. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: Correlation with tumor progression and postoperative survival. Clin Cancer Res 2002; 8: 450-456
41. Bremnes RM, Veve R, Gabrielson E, Hirsch FR, Baron A, Bemis L, Gemmill RM, Drabkin HA, Franklin WA. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J Clin Oncol 2002; 20: 2417-2428
42. Hugh TJ, Dillon SA, Taylor BA, Pignatelli M. Poston GJ, Kinsella AR. Cadherin-catenin expression in primary colorectal cancer: A survival analysis. Br J Cancer 1999; 80: 1046-1051
43. Pirinen RT, Hirvikoski P, Johansson RT, Hollmen S, Kosma VM. Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. J Clin Pathol 2001; 54: 391-395